ReviewTherapeutics and clinical risk management2014
Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation.
Alexander Gg TurpiePubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it